Top-News

Genvec News

Keine aktuellen Kursdaten verfügbar
WKN: A2DHJW
ISIN: US37246C4069
US-Symbol: GNVC
Typ: Aktie

Genvec News

16.06.17 - PR Newswire
Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition
Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition PR Newswire
23.04.17 - PR Newswire
Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of GenVec, Inc. - GNVC
Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of GenVec, Inc. - GNVC PR Newswire
17.02.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and
Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The ...
08.02.17 - PR Newswire
WeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC Shareholders
WeissLaw LLP: GenVec, Inc. Acquisition May Not Be in the Best Interests of GNVC Shareholders PR Newswire
02.02.17 - PR Newswire
GENVEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenVec, Inc.
GENVEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...
24.01.17 - PR Newswire
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
Intrexon to Acquire GenVec to Expand Industry-​Leading Gene Delivery Platform GenVec's AdenoVerse™ to be Integrated into Intrexon's Proprietary Synthetic Biology Platform PR ...
11.01.17 - PR Newswire
GenVec to Present at Phacilitate Cell & Gene Therapy World 2017
GenVec to Present at Phacilitate Cell & Gene Therapy World 2017 PR Newswire
05.01.17 - PR Newswire
GenVec Signs Option Agreement for Gene Editing and Cell Targeting Technology from Washington University in St. Louis
GenVec Signs Option Agreement for Gene Editing and Cell Targeting Technology from Washington University in St. Louis Provides Exclusive Access to Gene Editing and Pulmonary ...
01.12.16 - PR Newswire
GenVec Effects 1-for-10 Reverse Stock Split
GenVec Effects 1-for-10 Reverse Stock Split PR Newswire
04.11.16 - PR Newswire
GenVec Reports Third Quarter 2016 Financial Results
GenVec Reports Third Quarter 2016 Financial Results PR Newswire
28.09.16 - PR Newswire
GenVec To Present At 2016 Cell & Gene Meeting On The Mesa
GenVec To Present At 2016 Cell & Gene Meeting On The Mesa Wednesday, October 5th, 11 a.m. PDT/2:00 pm EDT PR Newswire
05.08.16 - PR Newswire
GenVec Reports Second Quarter 2016 Financial Results
GenVec Reports Second Quarter 2016 Financial Results PR Newswire
25.07.16 - PR Newswire
FDA Lifts Clinical Hold On CGF166
FDA Lifts Clinical Hold On CGF166 PR Newswire
02.05.16 - PR Newswire
GenVec Provides Update on Hearing Loss Clinical Program
GenVec Provides Update on Hearing Loss Clinical Program Data Safety Monitoring Board Recommends Trial Continue PR Newswire
02.03.16 - PR Newswire
GenVec To Release Fourth Quarter And Year-End 2015 Financial Results And Conduct A Conference Call On March 9, 2016
GenVec To Release Fourth Quarter And Year-End 2015 Financial Results And Conduct A Conference Call On March 9, 2016 PR Newswire
20.01.16 - PR Newswire
GenVec Provides Investor Update
GenVec Provides Investor Update Highlights Ongoing Initiatives Involving the AdenoVerse™ Gene Delivery Platform PR Newswire
02.12.15 - PR Newswire
GenVec Receives Notice of Allowance for Patent Application Providing Broad Protection of Its Gorilla Adenovectors
GenVec Receives Notice of Allowance for Patent Application Providing Broad Protection of Its Gorilla Adenovectors Composition of Matter Protection for Proprietary Gorilla Vectors ...
09.11.15 - PR Newswire
GenVec Reports Third Quarter 2015 Financial Results
GenVec Reports Third Quarter 2015 Financial Results PR Newswire
04.11.15 - PR Newswire
GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference
GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference Presentation Includes Emerging Data from Malaria Collaboration with NIAID PR Newswire
30.09.15 - PR Newswire
GenVec To Present At 2015 Stem Cell Meeting On The Mesa
GenVec To Present At 2015 Stem Cell Meeting On The Mesa Wednesday, October 7th, 5:15 pm Pacific/8:15 pm EDT PR Newswire

Newssuche

Videos

newspaper
18.04.24
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »